에 대한 최신 뉴스 Click Holdings (NASDAQ:CLIK) 주식

Click Holdings Ltd is a human resources solutions provider, specializing in offering comprehensive human resources solutions. It is focused on talent sourcing and the provision of temporary and permanent personnel to customers and also in placing professional accountants and company secretaries, registered nurses and healthcare workers as well as other blue-collar workers, for direct hire and contract staffing roles. The Company operates in three segments, 1) professional solution services, 2) nursing solution services and 3) logistic and other solution services. Maximum revenue is generated from Professional solution services and Hong Kong.

Click Holdings Ltd

Costco Wholesale Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) will release its third-quarter earnings results after the <a href="https://www.benzinga.com/quote/cost/earnings">closing bell on Thursday, May 29.</a>
Analysts expect the Issaquah, Washington-based company to report quarterly earnings at $4.23 per share, up from $3.78 per share in the year-ago period. Costco projects to report quarterly revenue at $63.1 billion, compared to $58.52 billion a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
The company beat revenue estimates in the second quarter, but has only beaten analyst estimates in four of the last 10 quarters overall.
Costco shares fell 0.5% to close at $1,013.14 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/cost/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Telsey Advisory Group analyst Joseph Feldman maintained an Outperform rating with a price target of $1,100 on May 8, 2025. This analyst has an accuracy rate of 65%.</li>
<li>Loop Capital analyst Laura Champine maintained a Buy rating and slashed the price target from $1,150 to $1,045 on April 9, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Stifel analyst Mark Astrachan maintained a Buy rating and cut the price target from $1,075 to $1,035 on March 20, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Evercore ISI Group analyst Greg Melich maintained an Outperform rating and raised the price target from $1,050 to $1,070 on March 11, 2025. This analyst has an accuracy rate of 81%.</li>
<li>Truist Securities analyst Scot Ciccarelli maintained a Hold rating and boosted the price target from $935 to $995 on March 7, 2025. This analyst has an accuracy rate of 71%.</li>
</ul>
Considering buying COST stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="565" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29051055/image-376-1024x565.png" alt="" class="wp-image-931147" style="width:597px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29051055/image-376-1024x565.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29051055/image-376-300x165.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29051055/image-376-768x424.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/29051055/image-376.png 1155w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative">Jim Cramer Says This Quantum Computing Stock Is &#8216;So High&#8217; And &#8216;Too Speculative&#8217;</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Price Target

Markets

Analyst Ratings

Trading Ideas

COST

Costco Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Iradimed Granted FDA 510(k) Clearance For Its MRidium 3870 Infusion Pump System

WIIM

Caleres shares are trading lower after the company reported Q1 financial results and missed its adjusted EPS and sales estimates. Additionally, the company announced it will suspend its guidance.

Barclays analyst Richard Hightower initiates coverage on Sun Communities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUI#NYSE">SUI</a>) with a Overweight rating and announces Price Target of $141.

Initiation

Barclays Initiates Coverage On Sun Communities with Overweight Rating, Announces Price Target of $141

QUBT

Quantum Computing shares are trading higher after the company announced it will join the Russell 2000 and Russell 3000 indexes on June 30.

U.S. stock futures were higher this morning, with the Dow futures gaining around 100 points on Thursday.
Shares of HP Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HPQ#NYSE">HPQ</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected second-quarter adjusted EPS results and issued third-quarter adjusted EPS <a href="https://www.benzinga.com/quote/hpq">guidance below estimates</a>.
HP reported second-quarter revenue of $13.22 billion, beating analyst estimates of $13.15 billion. The company reported second-quarter adjusted earnings of 71 cents per share, missing estimates of 80 cents per share, according to Benzinga Pro.
HP shares dipped 7.8% to $25.08 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul class="wp-block-list">
<li>Brooge Energy Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BROG#NASDAQ">BROG</a>) shares dipped 59.1% to $1.74 in pre-market trading. Brooge Energy announced voluntarily delisting from the Nasdaq.</li>
<li>SentinelOne, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) declined 13.7% to $16.98 in today's pre-market trading after the company reported first-quarter results and lowered its FY2026 sales guidance.</li>
<li>Movado Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOV#NYSE">MOV</a>) fell 12.6% to $15.22 in pre-market trading following weaker-than-expected quarterly results.</li>
<li>Intellia Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) shares declined 12.4% to $8.46 in pre-market trading.</li>
<li>Caleres, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAL#NYSE">CAL</a>) fell 10% to $14.74 in pre-market trading following downbeat quarterly earnings.</li>
<li>Joby Aviation, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JOBY#NYSE">JOBY</a>) fell 4.7% to $8.44 in pre-market trading. Joby Aviation shares jumped more than 28% on Wednesday after the company completed a round of raising capital, which included a $250 million investment from Toyota Motor.</li>
<li>Best Buy Co., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBY#NYSE">BBY</a>) slipped 3% to $69.36 in pre-market trading after the company reported a first-quarter earnings miss and lowered its guidance.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative"> </a>
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative">Jim Cramer Says This Quantum Computing Stock Is &#8216;So High&#8217; And &#8216;Too Speculative&#8217;</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Movers

BROG

JOBY

NTLA

HP Posts Downbeat Earnings, Joins SentinelOne, Best Buy And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Enterprise-Grade Hosting to Power Nationwide Membership Platform
&nbsp;Bridgeline Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLIN#NASDAQ">BLIN</a>), a leader in AI-driven marketing technology, announced a new managed hosting agreement with a major real estate association through Bridgeline's CMS platform, Unbound. The three-year contract exceeds $200,000 in total value.
The national association selected Bridgeline to provide dedicated hosting services to support the growth and performance needs of its nationwide membership platform. For example, Bridgeline's team will ensure the association's member portal stays fast and secure during peak usage, such as annual conference registration periods, while enabling seamless content updates across hundreds of local chapter sites.
Bridgeline's hosting and support services help enterprise clients optimize speed, enhance security, and ensure high availability, all backed by a team with deep CMS expertise.
"Organizations with complex digital operations are turning to Bridgeline for scalability, security, and performance," said Ari Kahn, CEO of Bridgeline. "This deal reflects our continued momentum in delivering enterprise-grade hosting solutions for mission-critical web platforms."

Contracts

BLIN

Bridgeline Digital Announces A New Managed Hosting Agreement With A Major Real Estate Association. The Three-Year Contract Exceeds $200K In Total Value.

Bernstein analyst Mark Moerdler maintains Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) with a Underperform and raises the price target from $243 to $255.

Bernstein Maintains Underperform on Salesforce, Raises Price Target to $255

Dell Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) will release its first-quarter earnings results after the closing <a href="https://www.benzinga.com/quote/DELL/earnings">bell on Thursday, May 29.</a>
Analysts expect the Texas-based company to report quarterly earnings at $1.69 per share, up from $1.27 per share in the year-ago period. According to data from Benzinga Pro, Dell projects quarterly revenue at $23.19 billion, compared to $22.24 billion a year earlier.
On May 23, Evercore ISI Group analyst Amit Daryanani maintained Dell with an Outperform rating and raised the price target from $120 to $140.
With the recent buzz around Dell, some investors may be eyeing potential gains from the company's dividends too. As of now, Dell offers an annual dividend yield of 1.85%, which is a quarterly dividend amount of 53 cents per share ($2.10 a year). &nbsp;
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $325,041 or around 2,857 shares. For a more modest $100 per month or $1,200 per year, you would need $64,963 or around 571 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($2.10 in this case). So, $6,000 / $2.10 = 2,857 ($500 per month), and $1,200 / $2.10 = 571 shares ($100 per month).
Note that dividend yield can change on a rolling basis, as the dividend payment and stock price both fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
DELL Price Action: Shares of Dell fell 0.2% to close at $113.77 on Wednesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45641430/jim-cramer-says-this-quantum-computing-stock-is-so-high-and-too-speculative">Jim Cramer Says This Quantum Computing Stock Is &#8216;So High&#8217; And &#8216;Too Speculative&#8217;</a></li>
</ul>
Photo: Shutterstock

Long Ideas

DELL

How To Earn $500 A Month From Dell Stock Ahead Of Q1 Earnings

<ul>
<li>Independent research from Johns Hopkins validates Lantern's data used to secure the FDA Rare Pediatric Disease Designation for LP-184 in ATRT and supports planned pediatric clinical trial</li>
</ul>
Lantern Pharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRN#NASDAQ">LTRN</a>), a clinical-stage biopharmaceutical company leveraging advanced AI and machine learning to transform the cost, pace, and timeline of oncology drug development, today announced promising preclinical data for LP-184 in atypical teratoid rhabdoid tumors (ATRT), a rare and aggressive pediatric brain cancer. The results were presented by <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fscholar.google.com%2Fcitations%3Fuser%3DVINW8PwAAAAJ%26hl%3Den&amp;esheet=54261980&amp;newsitemid=20250529981828&amp;lan=en-US&amp;anchor=Dr.+Eric+Raabe&amp;index=1&amp;md5=aa42f6561d176d8c23bb19fe83c71cda">Dr. Eric Raabe</a> of Johns Hopkins University School of Medicine at the Society for Neuro-Oncology's 8th Biennial Pediatric Neuro-Oncology Conference held May 15-17, 2025, in San Diego, California.
The data further validates the research that supported Lantern Pharma's Rare Pediatric Disease Designation from the FDA for LP-184 in ATRT and strengthens the scientific foundation for the company's planned pediatric clinical trial expected to begin in late 2025 or early 2026.
The data demonstrated that LP-184, a next-generation acylfulvene clinical-stage drug candidate, significantly extended survival in mouse models of ATRT. In the CHLA06 model, median survival increased from 20 days in the control group to 89 days in the LP-184 treatment group, representing a 345% improvement (p&lt;0.0001). In the BT37 model, median survival increased from 68 days to 98 days (p=0.0422).

LTRN

Lantern Pharma Announces Preclinical Data For LP-184 In Atypical Teratoid Rhabdoid Tumors, Rare And Aggressive Pediatric Brain Cancer

Quantum Computing Inc. To Join Russell 2000 And Russell 3000 On Jun. 30

Movado Group shares are trading lower after the company reported worse-than-expected Q1 financial results and announced it will withhold its FY26 guidance amid tariffs and planned price hikes.

Macro Economic Events

Econ #s

Economics

USA Initial Jobless Claims 240K Vs 229K Est: 226K Prior

USA Continuing Jobless Claims 1,919K Vs 1,890K Est; 1,893K Prior

Barclays analyst David Anderson downgrades Aspen Aerogels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASPN#NYSE">ASPN</a>) from Overweight to Equal-Weight and lowers the price target from $13 to $7.

Downgrades

ASPN

Barclays Downgrades Aspen Aerogels to Equal-Weight, Lowers Price Target to $7

USA Core PCE Prices (Q1) 3.40% Vs 3.50% Est.; 2.60% Prior

Build-A-Bear Workshop shares are trading higher after the company reported better-than-expected Q1 financial results.

Macro Notification

General

US GDP (QoQ) (Q1) -0.2% vs -0.3% Est.

TSHA

Taysha Gene Therapies shares are trading higher after the company provided details regarding the trial design for TSHA-102 and clinical data from part A of its REVELA Phase 1/2 trials. Additionally, the company announced a $200 million public offering and Chardan Capital raised its price target on the stock from $7 to $9.

Business Outlook &nbsp;
For the second quarter of 2025, the Company expects: &nbsp;
<ul>
<li>Deliveries of vehicles to be between 123,000 and 128,000 vehicles, representing a year-over-year increase of 13.3% to 17.9%.</li>
<li>Total revenues to be between RMB32.5 billion (US$4.5 billion) and RMB33.8 billion (US$4.7 billion), representing a year-over-year increase of 2.5% to 6.7%.</li>
</ul>

Guidance

UPDATE: Li Auto Expects Q2 Revenue Of RMB32.5B To RMB33.8B ($4.5B To $4.7B) Vs RMB32.94B Estimate, Q2 Deliveries Of 123K-128K, Up 13.3%-17.9% YoY

Press Releases

Click Holdings Limited Announces Closing of Initial Public Offering

Click Holdings Limited Reports Strong Growth in the First Half of 2024 Financial Results

CLICK announced to expand service to the Community Care Service Voucher scheme for elderly (CCSV scheme) in Hong Kong

Click announced the CEO Statement

CLIK Announces Strategic Acquisition of Leading Nursing Care Competitor, Expanding Market Presence and Talent Pool

CLIK Announces Pricing of $8.28 Million Public Offering of Ordinary Shares

CLIK Announces Closing of $8.28 Million Public Offering of Ordinary Shares

CLIK Announces Acquisition of Remaining 75% Equity Interest in Leading Nursing Care Competitor, Solidifying Market Leadership and Expanding Revenue Base

CLIK announces to collaborate with an advanced technology company under the Tencent SSV initiatives, to jointly promote 24-hour instant device service for senior citizens in Hong Kong; and also announces change to board composition

Peraso Inc. (NAS: PRSO) Surging on 2M mmWave Milestone, Defense & Satellite Boost – DKS, FL, HIT, CLIK News Inside

Comments

Click Holdings

뉴스

에 대한 최신 뉴스 Click Holdings (NASDAQ:CLIK) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌